Pfizer PFE0.84%increase; green up pointing triangle has sold 700 million shares in British consumer-healthcare business Haleon HLN 0.74%increase; green up pointing triangle for 2.50 billion pounds ...

Jan 15 (Reuters) - Pfizer (PFE.N), opens new tab will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon (HLN.L), opens new tab, lowering its stake in the British consumer healthcare ...

Haleon, líder mundial en Consumer Healthcare con marcas de referencia como Sensodyne, Voltadol, Multicentrum y Corega, ha consolidado a lo largo de 2024 su papel como agente de cambio y ...

(Bloomberg) -- Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne toothpaste. The deal raised around £2.5 billion ($3.1 billion ...

Pfizer plans to cut its stake in Haleon through an accelerated bookbuilding process to institutional investor, starting immediately. The New York drugmaker said Tuesday that the proposed sale ...

Haleon, conocida por marcas como Advil, Sensodyne y Centrum, opera en diversas categorías de salud, incluyendo Salud Bucal, Alivio del Dolor y Vitaminas, Minerales y Suplementos. El compromiso de ...

Pfizer (PFE) announces that it intends to sell approximately 700M ordinary shares in Haleon plc (HLN), representing approximately 7.7% of Haleon’s issued share capital. “There will be no sale ...

(RTTNews) - Pfizer Inc. (PFE) Wednesday announced the sale of 700 million shares in Haleon Plc (HLN), a British multinational consumer healthcare company, at 357 pence per share or approximately $ ...

The UK pharma group – now a therapeutics and vaccines pure-play since the spin-off of Haleon in July – also raised its financial forecasts for the full year for the second time in consecutive ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...